首页 > 抗体蛋白 > 抗体
PE anti-mouse CD40 Antibody
产品名称:
PE anti-mouse CD40 Antibody
产品类别:
抗体
产品编号:
124609
产品应用:
124609
[价格]
规格 价格 库存
25µg ¥ 1080 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Recombinant mouse CD40 protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

For highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 124627 &124628) with a low?endotoxin limit?(Endotoxin < 0.01 EU/?g).

Application References

(PubMed link indicates BioLegend citation)
  1. Hasbold J, et al. 1994. Eur. J. Immunol. 24:1835.
  2. Bourgeois C, et al. 2002. Science 297:2060.
Product Citations
  1. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  2. Sun L, et al. 2021. Cancer Cell. :. PubMed
  3. Liu J, et al. 2019. Immunity. 50:600. PubMed
  4. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  5. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  6. Carlsson J, et al. 2015. PLoS One. 10: 0143741. PubMed
  7. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  8. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  9. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  10. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  11. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  12. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  13. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  14. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  15. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  16. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  17. Ding M, et al. 2019. Exp Ther Med. 18:2323. PubMed
  18. Ozeri E, et al. 2012. J Immunol. 189:146. PubMed
  19. Wang J, et al. 2017. Mol Med Rep. 16:8434. PubMed
  20. Ise W, et al. 2018. Immunity. 48:702. PubMed
  21. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  22. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  23. Wang Y, et al. 2009. Clin Cancer Res. 5.417361111. PubMed
  24. Qian J, et al. 2021. Int J Mol Sci. 22:. PubMed
  25. Mao L, et al. 2022. Front Immunol. 13:833418. PubMed
  26. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  27. Morris AB, et al. 2020. Immunity. 52(1):136-150.e6.. PubMed
  28. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  29. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  30. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  31. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  32. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  33. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  34. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  35. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  36. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  37. Kadir NA, et al. 2020. Pathogens. 9:00. PubMed
  38. Lee C, et al. 2011. J Leukoc Biol. 90:911. PubMed
  39. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  40. Wallner S, et al. 2013. PLoS One. 8:65178. PubMed
  41. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  42. Zhang H, et al. 2020. Cell Reports. 29(9):2659-2671.e6.. PubMed
  43. Lalor R, et al. 2019. Nutrients. 11. PubMed
  44. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  45. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  46. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  47. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  48. Lin YC, et al. 2020. Mol Med Rep. 22:4909. PubMed
  49. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
RRID
AB_1134084 (BioLegend Cat. No. 124609) AB_1134075 (BioLegend Cat. No. 124610)

Antigen Details

Structure
48 kD type I transmembrane glycoprotein, a member of the tumor necrosis factor receptor (TNFR) superfamily.
Distribution

Expressed on B lymphocytes and other antigen-presenting cells, such as macrophages, follicular dendritic cells, etc.

Function
Regulates B cell growth and differentiation and Ig isotype switching. Interaction of CD40 with its ligand, CD154, on activated T cells is important for immune response.
Ligand/Receptor
CD154 on T cells
Cell Type
Antigen-presenting cells, B cells, Dendritic cells, Macrophages
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Grewal IS, et al. 1998. Annu Rev Immunol 16:111.

Gene ID
21939 View all products for this Gene ID
UniProt
View information about CD40 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线